The matter surrounding Wockhardt’s’ codeine creation practices has ignited a major controversy. Reports surfaced suggesting possible data alteration and deficient oversight during the drug's production. This led to government scrutiny from the American regulatory body, culminating in production restrictions and prompting serious questions about